Healthtech · Deeptech · USA
Humane Genomics
Humane Genomics
Engineering cancer-killing viruses via a synthetic-biology platform
About
Humane Genomics is a New York City company developing precision cancer therapies by engineering cancer-killing RNA/oncolytic viruses using a synthetic-biology platform. In February 2025 it announced the close of a Series Seed financing round led by Union Square Ventures. It was founded in 2016 by Peter Weijmarshausen (CEO, formerly co-founder of Shapeways) and Andrew Hessel.
Latest news
Humane Genomics Raises Seed Funding
finsmes.com2025-02
Humane Genomics - Union Square Ventures
usv.com2025-02
Checking the news desk for fresh coverage…
Coverage gathered from public sources.
Why Healthtech
Founders using technology to widen access, lower cost and shift care from reactive to anticipatory - across diagnostics, chronic care, and life-sciences tooling.